Initial dose reduction of enzalutamide does not decrease the incidence of adverse events in castration-resistant prostate cancer
Table 5
Any grade of adverse events (AE) based on initial dose of enzalutamide.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Any grade of adverse events (AE) based on initial dose of enzalutamide.